Immuno-Expression of Endoglin and Smooth Muscle Actin in the Vessels of Brain Metastases. Is There a Rational for Anti-Angiogenic Therapy?
Despite ongoing clinical trials, the efficacy of anti-angiogenic drugs for the treatment of brain metastases (BM) is still questionable. The lower response rate to anti-angiogenic therapy in the presence of BM than in metastatic disease involving other sites suggests that BM may be insensitive to t...
Main Authors: | Valeria Barresi, Giovanni Branca, Maria Caffo, Rosario Caltabiano, Antonio Ieni, Enrica Vitarelli, Salvatore Lanzafame, Giovanni Tuccari |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2014-04-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | http://www.mdpi.com/1422-0067/15/4/5663 |
Similar Items
-
Role of Endoglin (CD105) in the Progression of Hepatocellular Carcinoma and Anti-Angiogenic Therapy
by: Aldona Kasprzak, et al.
Published: (2018-12-01) -
Endoglin (CD105) and VEGF as potential angiogenic and dissemination markers for colorectal cancer
by: Ana Nogués, et al.
Published: (2020-05-01) -
The Role of Endoglin in Hepatocellular Carcinoma
by: Kuo-Shyang Jeng, et al.
Published: (2021-03-01) -
Diagnostic and prognostic significance of serum soluble endoglin levels in preeclampsia and eclampsia
by: Rekha Sachan, et al.
Published: (2016-01-01) -
Structural and Functional Characteristics of a Soluble Form of Endoglin in the Context of Preeclampsia
by: Gregory, Allison
Published: (2011)